Comparison of lansoprazole and famotidine for gastric acid inhibition during the daytime and night-time in different CYP2C19 genotype groups-Reference-Cited by-同舟云学术

Comparison of lansoprazole and famotidine for gastric acid inhibition during the daytime and night-time in different CYP2C19 genotype groups

Published:2002-04 Issue:4 Volume:16 Page:837-846
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

Shirai N.,Furuta T.,Xiao F.,Kajimura M.,Hanai H.,Ohashi K.,Ishizaki T.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2036.2002.01229.x/fullpdf

Reference43 articles.

1. Review article: the pharmacology of rabeprazole;Williams;Aliment Pharmacol Ther,1999

2. Appropriate acid suppression for the management of gastro-oesophageal reflux disease;Bell;Digestion,1992

3. Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression;Burget;Gastroenterology,1990

4. Antisecretory activities of a novel proton pump inhibitor AG-1749 in dogs and rats;Satoh;J Pharmacol Exp Ther,1989

5. Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by proton pump inhibitor AG-1749;Nagaya;J Pharmacol Exp Ther,1989

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acid‐suppressive drugs: A systematic review and network meta‐analysis of their nocturnal acid‐inhibitory effect;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-12-12

2. Comparison of the acid suppression effects between low-dose esomeprazole and famotidine in healthy subjects;Int. Journal of Clinical Pharmacology and Therapeutics;2023-09-01

3. A Pharmacogenetics-Based Approach to Managing Gastroesophageal Reflux Disease: Current Perspectives and Future Steps;Pharmacogenomics and Personalized Medicine;2023-06

4. Influence of Cytochrome P450 2C19 Genotype on Helicobacter pylori Proton Pump Inhibitor-Amoxicillin-Clarithromycin Eradication Therapy: A Meta-Analysis;Frontiers in Pharmacology;2021-10-15

5. Effect of Antibiotic Susceptibility and CYP3A4/5 and CYP2C19 Genotype on the Outcome of Vonoprazan-Containing Helicobacter pylori Eradication Therapy;Antibiotics;2020-09-26